Neurocrine Switzerland clinical trials
Neurocrine Switzerland is the lead sponsor of 3 current clinical trials in our USA, Germany and EU (CTIS) registers. 1 is recruiting patients now. All registered phases are Phase 2. The drugs named most often in its trials are Crinecerfont. The most-studied condition is Congenital Adrenal Hyperplasia.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Neurocrine Switzerland
2 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
NCT07536269 · Congenital Adrenal Hyperplasia
Drug: Crinecerfont |
Phase 2 | Recruiting | 2026-07 | USA |
|
Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
NCT07187375 · ClinicalTrials.gov ↗ · Congenital Adrenal Hyperplasia
Drug: Crinecerfont |
Phase 2 | Active, closed | 2025-09 | Germany |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Neurocrine Switzerland in the EU trials register (CTIS)
1 trialAuthorised or ongoing trials in the EU Clinical Trials Information System with Neurocrine Switzerland as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
A Phase 1 single-ascending dose, multiple-ascending dose, and food effect study of NBI-1852737 in healthy adults
2026-527513-34-00 · CTIS ↗ · Hormonal diseases
|
Phase 1 | Authorised | Belgium |
Drugs in Neurocrine Switzerland trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Neurocrine Switzerland trials
1 conditionBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 1 | 1 |
| Clinical trials in Germany | 1 | 0 |
| EU register (CTIS) | 1 | — |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Congenital Adrenal Hyperplasia
| Sponsor | Trials |
|---|---|
| Crinetics Pharmaceuticals | 3 |
| Neurocrine Biosciences | 2 |
| H. Lundbeck | 1 |
Sponsors with the most current trials registered for this condition.
Questions about Neurocrine Switzerland trials
How many clinical trials does Neurocrine Switzerland sponsor?
Neurocrine Switzerland is the lead sponsor of 2 current trials on ClinicalTrials.gov in our USA and Germany registers, and 1 authorised or ongoing trial in the EU register (CTIS), as of the registry sync on 30 October 2026. Completed and withdrawn studies are not counted.
Are Neurocrine Switzerland trials recruiting?
Yes. 1 of its 2 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Neurocrine Switzerland testing?
Its current trials name 1 drug or biological as interventions. The most frequent are Crinecerfont (2). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 30 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.